Reporter

Chris Reidy

Reidy is a general assignment business reporter. He chiefly contributes to online coverage that focuses on breaking local business news. In the past, he has covered beats such as retail, advertising, and residential real estate.

Latest stories

GlaxoSmithKline contract could be worth up to $100m to Lionbridge Technologies

By Chris Reidy , Globe Staff

Lionbridge Technologies Inc. said Wednesday it has signed a four-year contract valued at between $80 million and $100 million to provide services to GlaxoSmithKline PLC, the British drug giant.

Fidelity: Weigh options before borrowing from your 401(k) plans

By Chris Reidy , Globe Staff

Millennials need to be especially aware of the consequences of borrowing from their 401(k) savings plans to buy a house, Fidelity Investments says.

Alere awarded gov’t contract to develop an advanced flu test

By Chris Reidy , Globe Staff

Alere Inc., a medical diagnostics company headquartered in Waltham, has signed a federal contract to develop a low-cost device that can diagnose influenza.

Sunovion agrees to sell rights to an asthma treatment for $45m

By Chris Reidy , Globe Staff

Sunovion Pharmaceuticals Inc., a Marlborough-based company perhaps best known for the insomnia drug Lunesta, has agreed to sell rights to its Xopenox Inhalation Solution to Akorn Inc. for $45 million.